ASSET | DATE | % RETURN |
---|---|---|
BioLife Solutions (BLFS) | 8/30/1991 - 10/31/1991 | 264.15% |
Biomerica (BMRA) | 8/30/1991 - 10/31/1991 | 166.43% |
Abeona Therapeutics (ABEO) | 8/30/1991 - 10/31/1991 | 122.11% |
CEL-SCI (CVM) | 8/30/1991 - 10/31/1991 | 108.33% |
Fonar (FONR) | 8/30/1991 - 10/31/1991 | 106.4% |
Envela (ELA) | 8/30/1991 - 10/31/1991 | 92.48% |
LCI Industries (LCII) | 8/30/1991 - 10/31/1991 | 81.81% |
Celldex Therapeutics (CLDX) | 8/30/1991 - 10/31/1991 | 74% |
STAAR Surgical (STAA) | 8/30/1991 - 10/31/1991 | 70.39% |
Plexus (PLXS) | 8/30/1991 - 10/31/1991 | 66.67% |
GT Biopharma (GTBP) | 8/30/1991 - 10/31/1991 | 66.67% |
IDEXX Laboratories (IDXX) | 8/30/1991 - 10/31/1991 | 61.17% |
Regeneron Pharmaceuticals (REGN) | 8/30/1991 - 10/31/1991 | 57.14% |
American Shared Hospital Service (AMS) | 8/30/1991 - 10/31/1991 | 56.52% |
Heron Therapeuti (HRTX) | 8/30/1991 - 10/31/1991 | 54.84% |
Cps Technologies (CPSH) | 8/30/1991 - 10/31/1991 | 52.94% |
CVD Equipment (CVV) | 8/30/1991 - 10/31/1991 | 50.08% |
Cato (CATO) | 8/30/1991 - 10/31/1991 | 50.01% |
National HealthCare (NHC) | 8/30/1991 - 10/31/1991 | 49.81% |
Nordson (NDSN) | 8/30/1991 - 10/31/1991 | 49.12% |
Thor Industries (THO) | 8/30/1991 - 10/31/1991 | 48.61% |
Escalade (ESCA) | 8/30/1991 - 10/31/1991 | 48.01% |
Wendy’s (WEN) | 8/30/1991 - 10/31/1991 | 47.35% |
Hologic (HOLX) | 8/30/1991 - 10/31/1991 | 44.44% |
Anixa Biosciences (ANIX) | 8/30/1991 - 10/31/1991 | 43.28% |